Key issues faced by the deafblind community will be highlighted on 18 June when a group of deafblind Australians, community, service and research organisations

Medicare is now in its 50th year, and much has changed since rebates were first made available for eye care consultations via the federal

Find out about low level red light therapy (RLRL) – an emerging treatment approach for myopia control – at an upcoming webinar to be

Skye Bioscience has announced it will discontinue clinical development and spending in ophthalmology and instead refocus on its obesity drug candidate.